SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.86−0.17 (-2.12%)
Close on Nov 13, 2026Market cap $1.59BP/E –Yield –
SELLAS Life Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
SELLAS Life Sciences's profit margin for the twelve months ending Dec 31, 2022 was -4130.1%. For fiscal 2022 it was -4130.1%, against -272.4% the year before. The highest annual figure on record is -272.4% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -4130.1% | −3857.7 |
| FY2021 | Dec 31, 2021 | -272.4% | +609.6 |
| FY2020 | Dec 31, 2020 | -881.9% | −489.1 |
| FY2014 | Dec 31, 2014 | -392.8% | +2690.3 |
| FY2013 | Dec 31, 2013 | -3083.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2022 | Mar 31, 2022 | -1674.4% | – |
| Q2 FY2021 | Jun 30, 2021 | -242.8% | – |
| Q1 FY2021 | Mar 31, 2021 | -42.2% | – |
| Q4 FY2020 | Dec 31, 2020 | -195.6% | – |
See a number that looks wrong?